Trial Profile
Retrospective study analysing the association of clinical factors with outcome after mogamulizumab therapy in adult T-cell leukemia-lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Therapeutic Use
- 29 Nov 2018 New trial record
- 01 Nov 2018 Results published in the International Journal of Hematology